• Cambridge Consultants (Cambridge, Massachusetts) said that Mark Manasas was named manager of the surgical & interventional products group. Cambridge Consultants offers solutions across a range of industries including medical technology, industrial and consumer products, transport, energy, cleantech and wireless communications.

Debra Lappin was named president of the Council for American Medical Innovation (Washington). Lappin, an attorney, has more than two decades of experience in health and science policy, leading a major patient advocacy organization and serving as a senior advisor to the directors of both the National Institutes of Health and Centers for Disease Control and Prevention. Lappin will continue to serve as a senior VP at B&D Consulting. The Council for American Medical Innovation says it is bringing together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation.

Greg Zdechlik was named COO of Exosome Diagnostics (New York). Zdechlik, an in vitro diagnostic industry veteran, has been with Roche Diagnostics for more than 22 years, including the last 15 years in the clinical molecular diagnostics field. Exosome makes non-invasive molecular oncology diagnostics to aid in early cancer detection and therapeutic selection.

Chris Barys was promoted to COO of FlowCardia (Sunnyvale, California). Previously, Barys was executive VP of sales and marketing at the company. FlowCardia makes endovascular CTO recanalization products.